Clinical Study on the Safety, Pharmacokinetics, and Efficacy of ScTIL (Genetically Modified Tumor Infiltrating Lymphocytes) in the Treatment of Gynecological Malignancies
Clinical trial NCT05342506 · UNKNOWN
Trial details
- NCT number
- NCT05342506
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-18
- Primary completion
- 2024-02-28
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.